Biocryst Pharmaceuticals paid its 4 named executives $26.3M in total in FY2025 (Dec). CEO Charles K. Gayer was paid $9.6M of that.
Pay$100 in the stock at the end of FY21 → $56
Pay of each named executive
Charles K. GayerPresident and Chief Executive Officer; Former Chief Commercial Officer
| FY2025 (Dec) | |||||||
| FY2024 (Dec) | |||||||
| FY2023 (Dec) | |||||||
| FY2022 (Dec) | Not disclosed |
4 years
Jon P. StonehouseFormer President and Chief Executive Officer
| FY2024 (Dec) | |||||||
| FY2023 (Dec) | |||||||
| FY2022 (Dec) | Not disclosed | ||||||
| FY2021 (Dec) | Not disclosed |
4 years
Babar GhiasChief Financial Officer
| FY2025 (Dec) |
1 year
Alane P. BarnesChief Legal Officer and Corporate Secretary
| FY2025 (Dec) | |||||||
| FY2024 (Dec) | |||||||
| FY2023 (Dec) | |||||||
| FY2022 (Dec) | Not disclosed |
4 years
Helen M. Thackray, M.D.Former Chief R&D Officer
| FY2025 (Dec) | |||||||
| FY2024 (Dec) | |||||||
| FY2023 (Dec) | |||||||
| FY2022 (Dec) | Not disclosed | ||||||
| FY2021 (Dec) | Not disclosed |
5 years
Anthony J. DoyleFormer Chief Financial Officer and Treasurer
| FY2024 (Dec) | |||||||
| FY2023 (Dec) | |||||||
| FY2022 (Dec) | Not disclosed | ||||||
| FY2021 (Dec) | Not disclosed |
4 years
CEO pay against the pay peers
In FY2025 (Dec), the median CEO pay of the 7 peers with pay on file was $10.4M. CEO pay of Biocryst Pharmaceuticals for that year is not on file.
- 1PTC Therapeutics
- 2INSMED
- 3Ultragenyx Pharmaceutical
- 4Mirum Pharmaceuticals
- 5Adma Biologics
- 6Travere Therapeutics
- 7Harmony Biosciences Holdings
- 8Biocryst PharmaceuticalsThis companyNot disclosed
- 9Acadia PharmaceuticalsNot disclosed
- 10Amicus TherapeuticsNot disclosed
- 11Apellis PharmaceuticalsNot disclosed
- 12ArdelyxNot disclosed
- 13Arrowhead PharmaceuticalsNot disclosed
- 14Catalyst PharmaceuticalsNot disclosed
- 15Corcept TherapeuticsNot disclosed
- 16Dynavax TechnologiesNot disclosed
- 17Pacira BioSciencesNot disclosed
- 18Rhythm PharmaceuticalsNot disclosed
- 19SIGA TechnologiesNot disclosed
Pay of each named executive comes from the Summary Compensation Table of each proxy statement. Realized pay adds the value of options used and stock that vested. CEO pay of each peer comes from its own Pay versus Performance table.